Patent Number: 6,515,117

Title: C-aryl glucoside SGLT2 inhibitors and method

Abstract: An SGLT2 inhibiting compound is provided having the formula ##STR1## A method is also provided for treating diabetes and related diseases employing an SGLT2 inhibiting amount of the above compound alone or in combination with another antidiabetic agent or other therapeutic agent.

Inventors: Ellsworth; Bruce (Princeton, NJ), Washburn; William N. (Titusville, NJ), Sher; Philip M. (Plainsboro, NJ), Wu; Gang (Princeton, NJ), Meng; Wei (Pennington, NJ)

Assignee: Bristol-Myers Squibb Company

International Classification: A61K 45/06 (20060101); A61K 31/7028 (20060101); A61K 31/7034 (20060101); A61K 31/70 (20060101); C07H 15/00 (20060101); C07C 43/225 (20060101); C07C 49/84 (20060101); A61K 45/00 (20060101); C07H 15/203 (20060101); C07C 43/00 (20060101); C07C 49/00 (20060101); C07C 45/46 (20060101); C07C 45/00 (20060101); C07H 015/20 (); A61K 031/70 ()

Expiration Date: 02/04/2020